Four prognosis‐associated and glucose metabolism‐related genes (SERP1, CTSC, RAP2B, and SSR4) were ascertained, with the ROC curve results indicating that it may present promising efficacy in predicting the development and outcome of ESCC in both internal and external cohorts. The gene discussed is SSR4; the disease is esophageal squamous cell carcinoma.